---
title: "Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neopla"
id: "pubmed-42758401"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42758401"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42758401/"
doi: "10.1007/s11899-026-00790-5"
published_at: "2026-09-18T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neopla
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42758401
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42758401/)
- **DOI:** [10.1007/s11899-026-00790-5](https://doi.org/10.1007%2Fs11899-026-00790-5)
- **Published At:** 2026-09-18T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- This item is a 2026 peer-reviewed review titled “Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026.” It appears in Curr Hematol Malig Rep (2026 Sep 18;21[1]:21) and is indexed with PMID 42758401 and DOI 10.1007/s11899-026-00790-5. - The article is a multi-author, multi-institutional review involving authors from North America and Asia, including Weill Cornell Medicine, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Seoul St. Mary’s Hospital, The University of Hong Kong, MD Anderson Cancer Center, Huntsman Cancer Institute, Mount Sinai, The University of Kansas, Washington University, University of Miyazaki, UNC Chapel Hill, Peking Union Medical College Hospital, Pharmaessentia Corporation, Stony Brook University, and Wake Forest University School of Medicine. - The paper’s stated topical focus (from the title) is on **molecular response**, **event-free survival**, and **treatment-free remission** in **myeloproliferative neoplasms (MPNs)**, and it includes insights drawn from the MPN Asia 2026 meeting. - The PubMed page provides bibliographic metadata (authors, affiliations, journal, publication date, DOI, PMID) but the PubMed entry content available here does not include the article abstract or the detailed review content; specific findings, data, recommendations, or conclusions were not reported on the PubMed summary page used as the source. - Readers seeking the full text, abstract, or detailed evidence and recommendations will need to access the journal directly or use the DOI/link; the PubMed entry metadata confirms publication but does not provide the review’s substantive content on this page. - Conflict-of-interest, references, MeSH terms, and other detailed sections are listed on the PubMed record navigation but the substantive text and summary were not present in the captured source content.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42758401/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42758401%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42758401/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42758401/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42758401/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/c24ab723-7c80-48cd-9c68-022ded852586/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42758401/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42758401/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42758401/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42758401%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42758401%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42758401/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42758401/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42758401/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42758401/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42758401/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42758401/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42758401/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42758401/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/42758401/#references) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/42758401/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42758401/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42758401/#substances) Title & authors Abstract Conflict of interest statement References Publication types MeSH terms Substances Review Curr Hematol Malig Rep Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Curr+Hematol+Malig+Rep%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Curr+Hematol+Malig+Rep%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42758401/) . 2026 Sep 18;21(1):21. doi: 10.1007/s11899-026-00790-5. # Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026 [Ghaith Abu-Zeinah](https://pubmed.ncbi.nlm.nih.gov/?term=Abu-Zeinah+G&cauthor_id=42758401)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-1 "Myeloproliferative Neoplasms Center, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA."), [Gabriela S Hobbs](https://pubmed.ncbi.nlm.nih.gov/?term=Hobbs+GS&cauthor_id=42758401)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-2 "Leukemia Service, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA."), [Raajit K Rampal](https://pubmed.ncbi.nlm.nih.gov/?term=Rampal+RK&cauthor_id=42758401)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-3 "Center for Hematologic Malignancies and Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA."), [Sung-Eun Lee](https://pubmed.ncbi.nlm.nih.gov/?term=Lee+SE&cauthor_id=42758401)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-4 "Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea."), [Harinder Gill](https://pubmed.ncbi.nlm.nih.gov/?term=Gill+H&cauthor_id=42758401)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-5 "Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China."), [Rami Komrokji](https://pubmed.ncbi.nlm.nih.gov/?term=Komrokji+R&cauthor_id=42758401)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-6 "Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA."), [Tsewang Tashi](https://pubmed.ncbi.nlm.nih.gov/?term=Tashi+T&cauthor_id=42758401)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-7 "Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA."), [Prithviraj Bose](https://pubmed.ncbi.nlm.nih.gov/?term=Bose+P&cauthor_id=42758401)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-8 "Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA."), [John Mascarenhas](https://pubmed.ncbi.nlm.nih.gov/?term=Mascarenhas+J&cauthor_id=42758401)[ 9 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-9 "Center of Excellence in Blood Cancers and Myeloid Disorders, Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA."), [Abdulraheem Yacoub](https://pubmed.ncbi.nlm.nih.gov/?term=Yacoub+A&cauthor_id=42758401)[ 10 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-10 "Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA."), [Stephen T Oh](https://pubmed.ncbi.nlm.nih.gov/?term=Oh+ST&cauthor_id=42758401)[ 11 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-11 "Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA."), [Kazuya Shimoda](https://pubmed.ncbi.nlm.nih.gov/?term=Shimoda+K&cauthor_id=42758401)[ 12 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-12 "Division of Hematology, Diabetes and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."), [Brandi N Reeves](https://pubmed.ncbi.nlm.nih.gov/?term=Reeves+BN&cauthor_id=42758401)[ 13 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-13 "Division of Hematology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA."), [Minghui Duan](https://pubmed.ncbi.nlm.nih.gov/?term=Duan+M&cauthor_id=42758401)[ 14 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-14 "Department of Hematology, Peking Union Medical College Hospital, Beijing, China."), [Lennex Hsueh-Lin Yu](https://pubmed.ncbi.nlm.nih.gov/?term=Yu+LH&cauthor_id=42758401)[ 15 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-15 "Pharmaessentia Corporation, Taipei, Taiwan."), [Albert Qin](https://pubmed.ncbi.nlm.nih.gov/?term=Qin+A&cauthor_id=42758401)[ 15 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-15 "Pharmaessentia Corporation, Taipei, Taiwan."), [Josef T Prchal](https://pubmed.ncbi.nlm.nih.gov/?term=Prchal+JT&cauthor_id=42758401)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-7 "Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA."), [Kenneth Kaushansky](https://pubmed.ncbi.nlm.nih.gov/?term=Kaushansky+K&cauthor_id=42758401)[ 16 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-16 "Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, USA."), [Ruben A Mesa](https://pubmed.ncbi.nlm.nih.gov/?term=Mesa+RA&cauthor_id=42758401)[ 17 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#full-view-affiliation-17 "Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Advocate Health Cancer National Service Line, Wake Forest University School of Medicine, Winston-Salem, NC, 28204, USA. ruben.mesa@advocatehealth.org.") Affiliations Expand ### Affiliations * 1 Myeloproliferative Neoplasms Center, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA. * 2 Leukemia Service, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. * 3 Center for Hematologic Malignancies and Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. * 4 Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea. * 5 Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China. * 6 Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. * 7 Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA. * 8 Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. * 9 Center of Excellence in Blood Cancers and Myeloid Disorders, Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA. * 10 Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA. * 11 Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA. * 12 Division of Hematology, Diabetes and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. * 13 Division of Hematology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. * 14 Department of Hematology, Peking Union Medical College Hospital, Beijing, China. * 15 Pharmaessentia Corporation, Taipei, Taiwan. * 16 Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, USA. * 17 Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Advocate Health Cancer National Service Line, Wake Forest University School of Medicine, Winston-Salem, NC, 28204, USA. ruben.mesa@advocatehealth.org. * PMID: **42758401** * DOI: [ 10.1007/s11899-026-00790-5 ](https://doi.org/10.1007/s11899-026-00790-5) Item in Clipboard Review # Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026 Ghaith Abu-Zeinah et al. Curr Hematol Malig Rep. 2026. Show details Display options Display options Format Abstract PubMed PMID Curr Hematol Malig Rep Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Curr+Hematol+Malig+Rep%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Curr+Hematol+Malig+Rep%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42758401/) . 2026 Sep 18;21(1):21. doi: 10.1007/s11899-026-00790-5. ### Authors [Ghaith Abu-Zeinah](https://pubmed.ncbi.nlm.nih.gov/?term=Abu-Zeinah+G&cauthor_id=42758401)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-1 "Myeloproliferative Neoplasms Center, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA."), [Gabriela S Hobbs](https://pubmed.ncbi.nlm.nih.gov/?term=Hobbs+GS&cauthor_id=42758401)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-2 "Leukemia Service, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA."), [Raajit K Rampal](https://pubmed.ncbi.nlm.nih.gov/?term=Rampal+RK&cauthor_id=42758401)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-3 "Center for Hematologic Malignancies and Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA."), [Sung-Eun Lee](https://pubmed.ncbi.nlm.nih.gov/?term=Lee+SE&cauthor_id=42758401)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-4 "Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea."), [Harinder Gill](https://pubmed.ncbi.nlm.nih.gov/?term=Gill+H&cauthor_id=42758401)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-5 "Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China."), [Rami Komrokji](https://pubmed.ncbi.nlm.nih.gov/?term=Komrokji+R&cauthor_id=42758401)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-6 "Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA."), [Tsewang Tashi](https://pubmed.ncbi.nlm.nih.gov/?term=Tashi+T&cauthor_id=42758401)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-7 "Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA."), [Prithviraj Bose](https://pubmed.ncbi.nlm.nih.gov/?term=Bose+P&cauthor_id=42758401)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-8 "Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA."), [John Mascarenhas](https://pubmed.ncbi.nlm.nih.gov/?term=Mascarenhas+J&cauthor_id=42758401)[ 9 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-9 "Center of Excellence in Blood Cancers and Myeloid Disorders, Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA."), [Abdulraheem Yacoub](https://pubmed.ncbi.nlm.nih.gov/?term=Yacoub+A&cauthor_id=42758401)[ 10 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-10 "Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA."), [Stephen T Oh](https://pubmed.ncbi.nlm.nih.gov/?term=Oh+ST&cauthor_id=42758401)[ 11 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-11 "Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA."), [Kazuya Shimoda](https://pubmed.ncbi.nlm.nih.gov/?term=Shimoda+K&cauthor_id=42758401)[ 12 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-12 "Division of Hematology, Diabetes and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan."), [Brandi N Reeves](https://pubmed.ncbi.nlm.nih.gov/?term=Reeves+BN&cauthor_id=42758401)[ 13 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-13 "Division of Hematology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA."), [Minghui Duan](https://pubmed.ncbi.nlm.nih.gov/?term=Duan+M&cauthor_id=42758401)[ 14 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-14 "Department of Hematology, Peking Union Medical College Hospital, Beijing, China."), [Lennex Hsueh-Lin Yu](https://pubmed.ncbi.nlm.nih.gov/?term=Yu+LH&cauthor_id=42758401)[ 15 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-15 "Pharmaessentia Corporation, Taipei, Taiwan."), [Albert Qin](https://pubmed.ncbi.nlm.nih.gov/?term=Qin+A&cauthor_id=42758401)[ 15 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-15 "Pharmaessentia Corporation, Taipei, Taiwan."), [Josef T Prchal](https://pubmed.ncbi.nlm.nih.gov/?term=Prchal+JT&cauthor_id=42758401)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-7 "Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA."), [Kenneth Kaushansky](https://pubmed.ncbi.nlm.nih.gov/?term=Kaushansky+K&cauthor_id=42758401)[ 16 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-16 "Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, USA."), [Ruben A Mesa](https://pubmed.ncbi.nlm.nih.gov/?term=Mesa+RA&cauthor_id=42758401)[ 17 ](https://pubmed.ncbi.nlm.nih.gov/42758401/#short-view-affiliation-17 "Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Advocate Health Cancer National Service Line, Wake Forest University School of Medicine, Winston-Salem, NC, 28204, USA. ruben.mesa@advocatehealth.org.") ### Affiliations * 1
## Related Clinical Research

- [Structured aerobic exercise linked to lower cancer recurrence and improved survival](https://medichelpline.com/clinical-feed/medical-news-today-0-aerobic-exercise-could-help-improve-outlook-after-cancer-treatment.md)
- [Obesity-associated inflammation and cancer: mechanisms linking adipose immune changes to tumor risk](https://medichelpline.com/clinical-feed/frontiers-in-immunology-6-obesity-associated-inflammation-and-cancer-molecular-mechanisms-evidence-gaps.md)
- [8-hour time-restricted eating yields greater weight loss but not consistent blood pressure benefits](https://medichelpline.com/clinical-feed/medical-news-today-0-16-8-intermittent-fasting-best-for-weight-loss-but-not-for-blood-pressure.md)
- [TP53-driven clonal evolution from bone marrow failure to leukemia in ERCC6L2 disease](https://medichelpline.com/clinical-feed/medrxiv-13-intense-tp53-pathway-selection-drives-clonal-evolution-from-bone-marrow-failure.md)
- [Sellas Phase 3 REGAL trial for galinpepimut-S faces delays and likely negative outcome in AML](https://medichelpline.com/clinical-feed/stat-news-1-stat-a-sellas-immunotherapy-study-long-delayed-will-end-in-failure.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.